These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3885586)

  • 21. Captopril: pharmacology, metabolism and disposition.
    Migdalof BH; Antonaccio MJ; McKinstry DN; Singhvi SM; Lan SJ; Egli P; Kripalani KJ
    Drug Metab Rev; 1984; 15(4):841-69. PubMed ID: 6437780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of central angiotensin I conversion by oral captopril.
    Marson O; Ribeiro AB; Tufik S; Kohlmann O; Ramos OL
    Braz J Med Biol Res; 1981 Apr; 14(1):73-6. PubMed ID: 6272920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats.
    Barry DI; Paulson OB; Jarden JO; Juhler M; Graham DI; Strandgaard S
    Am J Med; 1984 May; 76(5B):79-85. PubMed ID: 6328989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of acute oral administration of captopril and MK-421 on vascular angiotensin converting enzyme activity in the spontaneously hypertensive rat.
    Cohen ML; Wiley KS; Kurz KD
    Life Sci; 1983 Feb; 32(6):565-9. PubMed ID: 6300600
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of nisoldipine. II. Distribution to and elimination from tissues and organs following single or repeated administration of [14C]nisoldipine to rats and dogs.
    Ahr HJ; Krause HP; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1099-104. PubMed ID: 3196403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-methylation of captopril. Demonstration of captopril thiol methyltransferase activity in human erythrocytes and enzyme distribution in rat tissues.
    Drummer OH; Miach P; Jarrott B
    Biochem Pharmacol; 1983 May; 32(10):1557-62. PubMed ID: 6344869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic administration of captopril on blood pressure and the renin-angiotensin-aldosterone system in normotensive rats.
    Ishii M; Goto A; Kimura K; Hirata Y; Yamakado M; Takeda T; Murao S
    Jpn Heart J; 1983 Jul; 24(4):623-31. PubMed ID: 6358579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril kinetics.
    Duchin KL; Singhvi SM; Willard DA; Migdalof BH; McKinstry DN
    Clin Pharmacol Ther; 1982 Apr; 31(4):452-8. PubMed ID: 7037265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic study in rats after single intravenous and oral administrations of [14C]-ITF-296.
    Giachetti C; Bertolino M; Canali S; Lombardini E; Monzani MV; Sala A; Zanolo G
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):230-8. PubMed ID: 9725487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
    Matsumoto K; Nambu K; Fujii T; Takeyama K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):52-4. PubMed ID: 3006711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The absorption, tissue distribution and excretion of di-n-octyltin dichloride in rats.
    Penninks AH; Hilgers L; Seinen W
    Toxicology; 1987 Apr; 44(1):107-20. PubMed ID: 3564046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of food on the bioavailability of captopril in healthy subjects.
    Singhvi SM; McKinstry DN; Shaw JM; Willard DA; Migdalof BH
    J Clin Pharmacol; 1982; 22(2-3):135-40. PubMed ID: 7040498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption and bioavailability of captopril in mice and rats after administration by gavage and in the diet.
    Singhvi SM; Kripalani KJ; Dean AV; Keim GR; Kulesza JS; Meeker FS; Ross JJ; Shaw JM; Migdalof BH
    J Pharm Sci; 1981 Aug; 70(8):885-8. PubMed ID: 7031222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on absorption, distribution and excretion of 14C labeled (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)-1,4- dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluene-sulfonate hydrate (14C-T-3262) in rats and mice].
    Maeda T; Sakai H; Hayakawa H; Hayashi K; Yoneda K
    Jpn J Antibiot; 1989 Apr; 42(4):854-67. PubMed ID: 2769938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.